The class of drugs currently prescribed to treat male erectile dysfunction has the potential to be repurposed for use in cancer treatment. Cancer specialists would like to prescribe existing medications like Viagra and Cialis since they are affordable and approved for use, thus save significant research money otherwise spent on expensive drug discovery.
Researchers from Japan have bred genetically engineered chickens that lay eggs carrying interferon beta, a protein known to fight diseases like cancer and hepatitis. The method could eventually cut the cost of producing this important cancer-fighting agent by 90 percent.
Night shift work has been consistently associated with higher risk for cardiovascular disease, cancer, insomnia, depression and irritable bowel syndrome. Exposure to light at night is not only leaving scars on people’s well being but is affecting wildlife and entire ecosystems, it wastes energy, money and gives astronomers headaches.
Scientists from the University Of Geneva (UNIGE) and the University of Basel have created artificial viruses that can be used to target cancer. This virus is fashioned to act as an alarm for the immune system and instigate killer T cells to fight the tumour.
European researchers demonstrated that a low dose of delta-9-tetrahydrocannabinol (THC), the main active substance of cannabis, profoundly reduced age-related cognitive impairment in mice. The drug increased behavioural performance and rejuvenated the elderly brain, closely resembling that of young, untreated animals.
The future of molecular diagnostics is looking particularly bright as international teams of researchers and entrepreneurs make profound headway in the development of disease-sensing instruments.
Researchers at Harvard University developed an effective personalized cancer vaccine that seems to have prevented early tumour relapse in 12 skin cancer patients. The vaccine targeted 20 tumour-specific proteins unique to each of the patients enrolled, keeping all free of cancer over 2 years after the trial.
A new breast cancer drug combination significantly shrunk and eliminated tumours in 28% of women tested in just 11 days. The novel treatment involves a combination of pre-chemotherapy drugs lapatinib and trastuzumab that target HER2-positive tumours.
British scientists developed a revolutionary method for screening cancer using breath-analyzing technology. In a preliminary study involving more than 300 patients the instrument was capable of diagnosing those with esophageal and stomach cancer with 85% accuracy.
Scientists developed a strain of Salmonella that fights aggressive brain cancers which produced a remarkable 20% rate of tumor remission in a rat model, where there are normally no survivors. The bacteria were genetically equipped with a sophisticated tumor-homing mechanism along with cancer fighting weapons, causing the tumors to effectively self-destruct.